Truly Translational was founded in 2011 by former AstraZeneca employees with extensive experience from the life science sector including pharmaceutical and biotech companies.
Our experiences span from pre-clinical to early clinical drug discovery and development, and include e.g. expertise in pharmacology, pharmacokinetics and pharmacodynamics, design of in vitro and in vivo studies for both small molecules and biologicals, safety evaluation plans incl. outsourcing and coordination of activities, as well as supporting documentation for CTA submission.
We have worked with project and line management, as well as business development with cross-functional teams in an international environment.
Our aim is to bring projects from in vitro studies and animal models into concept testing in patients.